Medical Cannabis Research Vote Marks Another Win for Patients and Reform

Lifting Restrictions on Research Will Improve Lives of Patients and Veterans, Says NCR

WASHINGTON – The National Cannabis Roundtable (NCR) today applauded the passage of the Medical Marijuana Research Act (HR 3797) by the U.S. House of Representatives, marking another win for cannabis reform in the final days of the Congress.  Today’s vote comes on the heels of the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act).

“Today’s vote is another win for the patients and the cannabis industry as we continue to build momentum for comprehensive reform,” said Saphira Galoob, NCR Executive Director.  “Removing federal restrictions prohibiting medical cannabis research and allowing public-private research partnerships could improve the lives of veterans and patients and provide another tool for public health officials to combat the opioid crisis.”

National Cannabis Roundtable

The National Cannabis Roundtable promotes common sense federal regulation, tax equality and financial services reform and supports changing federal law to acknowledge states’ rights to regulate and manage cannabis policy.  The membership of NCR represents every aspect of the cannabis supply chain. Our members operate in states with legal cannabis programs. We are growers, processors, retailers, wellness centers, investors, entrepreneurs, and publicly traded companies.  Learn more at